ADJ PROFESSOR, U of I
CEO, PHARMACEUTICAL SCIENCES
Sarfaraz
Coined the term Biosimilar
K. niazi
ADJ PROFESSOR, U of I
CEO, PHARMACEUTICAL SCIENCES
Sarfaraz
K. niazi
Coined the term “Biosimilar” and created the first biosimilar company in the US.
Inventor,
Author & Advisor
Meet Sarfaraz K. Niazi
trailblazer in biosimilars, mrna vaccines, and biotech
Sarfaraz K. Niazi’s work spans academia and industry, with impactful research and advisory roles for governments worldwide. His innovations promise safer, more accessible treatments, marking him as a true visionary in pharmaceutical science.
My Vision
To pioneer accessible, life-saving treatments worldwide, advancing healthcare equity and fostering innovation in pharmacy.
My Mission
To revolutionize healthcare through groundbreaking research and empowering the next generation of scientists.
My Goal
To drive transformative change, delivering affordable and effective therapies to every corner of the globe, ensuring no one is left behind.
MY WORK
Some of the Curated publications
Explore Sarfaraz K. Niazi’s curated publications, offering invaluable insights into biosimilars, mRNA vaccines, and biotechnology. Each publication represents a milestone in advancing healthcare and shaping the future of medicine, making them indispensable resources for scholars, researchers, and industry professionals alike.
New Release • April 2024
biosimilars and interchangeable biologics
A comprehensive guide regulating the commercial and scientific dimensions of biosimilars. Providing insights into market dynamics, development strategies, and challenges.
BLOG
journEy of thoughtS
Embark on a captivating journey through the mind of Sarfaraz K. Niazi with his blog repository, where ideas flourish and insights abound.
By Niazi
Epstein Syndrome
By Niazi
The Power of Belief
